The Valley Desk

NCT06957366 · Interventional trial

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Overall registry status Recruiting

Conditions Atrial Fibrillation (AF), VTE

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov